A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a new ...
BDC-3042 is a proprietary agonist antibody that targets dectin-2, an immune-activating receptor expressed by tumor-associated macrophages (TAMs). This single-agent, dose-escalation Phase 1 clinical ...
A new study explores how epigenetic markers—chemical modifications that influence gene activity—can help predict the risk of ...
Black Americans face higher rates and lower survival. Research explores biological, social factors, and disparities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback